Inhibition of LERK-2-mediated cell adhesion
US6514497B1 · kind B1 · utility
14Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 1998 |
| Grant date | Feb 4, 2003 |
| Priority date | — |
| Expiry date | Oct 1, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/405
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods of modulating LERK-2-mediated cell adhesion, as well as methods of modulating angiogenesis and inflammation are described. Also described are agents such as antibodies which can modulate LERK-2-mediated cell adhesion, as well as methods of treating angiogenic diseases and inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.